OU Medicine debt remains high after HCA spinout, S&P says

Oklahoma City-based OU Medicine’s financial outlook is stable, but its profile still reflects “very high debt levels” after its spinout from Nashville, Tenn.-based HCA Healthcare in 2018, according to S&P Global Ratings.

Advertisement

In February 2018, OU Medicine assumed ownership of OU Medical System hospital facilities in the Oklahoma City area from HCA. At the time, OU Medicine had planned large capital investments at the medical center and said it would hire 300 employees by the end of 2018, adding $20 million to its payroll.

With the upcoming launch of its Epic IT system for revenue cycle management and EHR services, OU Medicine will close the last of its transitional agreements with HCA. S&P said it views that as a “significant achievement.” 

Outside of the HCA deal and Epic installation, OU Medicine also returned about $36 million in CARES Act grants, S&P said.

S&P said it expects the health system’s cash on hand to possibly be improved by increased volume, added capacity and Oklahoma’s expansion of Medicaid. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

  • Baylor College of Medicine and Texas Children’s Hospital established an affiliation more than 70 years ago in the Texas Medical…

  • Fitch revised Ontario, Calif.-based Prime Healthcare Services’ outlook to positive and affirms its “B” rating.  The revised outlook reflects Fitch’s…

  • Brentwood, Tenn.-based Lifepoint Health, a health system owned by private equity firm Apollo Global Management, has largely grown over the…

Advertisement

Comments are closed.